MAPT and Alzheimer disease: In the context of AD, the multiple links connecting CK1 to various pathophysiological issues, its dual capacity to act on the two most important pathways (tau and amyloid beta), and the existence of well-defined neuronal specific isoforms, makes it a special and highly relevant target.